{"transactions":[{"id":780836,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-13T20:14:02.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":0.95,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001684258-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000168425826000003/ownership.xml","form_type":"4"}},{"id":1161183,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-02T21:20:43.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":3.34,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-062937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000095017025062937/ownership.xml","form_type":"4"}},{"id":1203760,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T23:07:42.000Z","date":"2025-03-17","kind":"purchase","planned":false,"acquired":true,"shares":3750,"price":4,"value":15000.0,"ownership":{"direct":true},"balance_after":9750,"source":{"system":"sec-edgar","filing":"0000950170-25-040600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000095017025040600/ownership.xml","form_type":"4"}},{"id":1503712,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T23:27:41.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":24000,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000950170-24-064229","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000095017024064229/ownership.xml","form_type":"4"}},{"id":1884659,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T20:29:03.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":12000,"derivative":{"exercise_price":2.52,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-031012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919123031012/doc4.xml","form_type":"4"}},{"id":1911332,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-04-28T20:52:18.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-026064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919123026064/doc4.xml","form_type":"4"}},{"id":1911331,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-04-28T20:52:18.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-026064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919123026064/doc4.xml","form_type":"4"}},{"id":2288757,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-28T23:46:57.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-026089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919122026089/doc4.xml","form_type":"4"}},{"id":2735898,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-30T00:08:33.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":4.21,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-21-029121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919121029121/doc4.xml","form_type":"4"}},{"id":2854860,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T02:01:06.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on January 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001019056-21-000142","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905621000142/gross.xml","form_type":"4"}},{"id":2854859,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T02:01:06.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":16500,"derivative":{"exercise_price":33.5,"expiration_date":"2031-01-29","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001019056-21-000142","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905621000142/gross.xml","form_type":"4"}},{"id":3074095,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":2140,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":2140,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074094,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":7784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":7784,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":7784},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074093,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This stock option award provides for vesting in three approximately equal annual installments beginning on February 28, 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":21.28,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074092,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This stock option award provides for vesting in three approximately equal annual installments beginning on March 9, 2019. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":43.82,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074091,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option award vested over three years, and the final one-third vested on June 1, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074090,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award vested over three years, and the final one-third vested on February 24, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":27.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074089,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":3908,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award vested over three years, and the final one-third vested on March 1, 2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.58,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3908},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074088,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award vested on March 10, 2018. This award was originally part of a grant from Emergent dated March 11, 2015, of which two-thirds were vested at the time of conversion to the issuer's equity pool."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":35.7,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":2779},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3074087,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:10.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2072,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award vested on March 10, 2017. This award was originally part of a grant from Emergent BioSolutions Inc. (\"Emergent\") dated March 11, 2014, of which two-thirds were vested at the time of conversion to the issuer's equity pool."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":34.58,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":2072},"source":{"system":"sec-edgar","filing":"0001019056-20-000451","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000451/gross.xml","form_type":"4"}},{"id":3156515,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T20:57:04.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":3.65,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-20-027966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919120027966/doc4.xml","form_type":"4"}},{"id":3200806,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-19T22:33:46.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":134800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on February 17, 2021."}],"balance_after":134800,"derivative":{"exercise_price":0.498,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":134800},"source":{"system":"sec-edgar","filing":"0001019056-20-000240","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905620000240/gross.xml","form_type":"4"}},{"id":3380338,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-06T01:52:12.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":122982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on November 1, 2020, the one-year anniversary of the grant date."}],"balance_after":122982,"derivative":{"exercise_price":0.576,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":122982},"source":{"system":"sec-edgar","filing":"0001019056-19-000612","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905619000612/gross.xml","form_type":"4"}},{"id":3471381,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-02T21:14:28.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":2285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019."}],"balance_after":2285,"derivative":{"exercise_price":5.1296,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":2285},"source":{"system":"sec-edgar","filing":"0001209191-19-040447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000120919119040447/doc4.xml","form_type":"4"}},{"id":3619270,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2019-03-05T02:04:26.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":9138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. 9,140 shares of common stock underlying the RSUs vested on each of March 1, 2017 and March 1, 2018, and the remaining 9,138 shares vested on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. 9,140 shares of common stock underlying the RSUs vested on each of March 1, 2017 and March 1, 2018, and the remaining 9,138 shares vested on March 1, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9138},"source":{"system":"sec-edgar","filing":"0001019056-19-000176","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905619000176/gross.xml","form_type":"4"}},{"id":3619269,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-05T02:04:26.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three approximately equal annual installments beginning on February 28, 2020."}],"balance_after":67400,"derivative":{"exercise_price":1.52,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-19-000176","document":"gross.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905619000176/gross.xml","form_type":"4"}},{"id":3619268,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-05T02:04:26.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":2710,"price":1.57,"value":4254.7,"ownership":{"direct":true},"balance_after":109583,"source":{"system":"sec-edgar","filing":"0001019056-19-000176","document":"gross.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905619000176/gross.xml","form_type":"4"}},{"id":3619267,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-05T02:04:26.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":9138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."}],"balance_after":112293,"source":{"system":"sec-edgar","filing":"0001019056-19-000176","document":"gross.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905619000176/gross.xml","form_type":"4"}},{"id":3998487,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2018-03-14T01:36:31.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018."}],"balance_after":9138,"derivative":{"underlying":"Common Stock","underlying_shares":9728},"source":{"system":"sec-edgar","filing":"0001019056-18-000433","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000433/gross_4.xml","form_type":"4"}},{"id":3998486,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2018-03-14T01:36:31.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":67400,"derivative":{"exercise_price":3.13,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-18-000433","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000433/gross_4.xml","form_type":"4"}},{"id":3998485,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-14T01:36:31.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":2282,"price":3.13,"value":7142.66,"ownership":{"direct":true},"balance_after":103155,"source":{"system":"sec-edgar","filing":"0001019056-18-000433","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000433/gross_4.xml","form_type":"4"}},{"id":3998484,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-14T01:36:31.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":9728,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":105437,"source":{"system":"sec-edgar","filing":"0001019056-18-000433","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000433/gross_4.xml","form_type":"4"}},{"id":4015621,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2018-03-06T00:37:53.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":9140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019."}],"balance_after":18866,"derivative":{"underlying":"Common Stock","underlying_shares":9140},"source":{"system":"sec-edgar","filing":"0001019056-18-000417","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000417/gross_4.xml","form_type":"4"}},{"id":4015620,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-06T00:37:53.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":9140,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":95709,"source":{"system":"sec-edgar","filing":"0001019056-18-000417","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000417/gross_4.xml","form_type":"4"}},{"id":4073836,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2018-02-07T00:22:35.000Z","date":"2018-02-03","kind":"exercise","acquired":false,"shares":18136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":28006,"derivative":{"underlying":"Common Stock","underlying_shares":18136},"source":{"system":"sec-edgar","filing":"0001019056-18-000289","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000289/gross_4.xml","form_type":"4"}},{"id":4073835,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-07T00:22:35.000Z","date":"2018-02-03","kind":"exercise","acquired":true,"shares":18136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":86569,"source":{"system":"sec-edgar","filing":"0001019056-18-000289","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905618000289/gross_4.xml","form_type":"4"}},{"id":4243758,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-08-03T19:59:42.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":38093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued on August 3, 2016 and fully vested on August 1, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued on August 3, 2016 and fully vested on August 1, 2017."}],"balance_after":46142,"derivative":{"underlying":"Common Stock","underlying_shares":38093},"source":{"system":"sec-edgar","filing":"0001019056-17-000648","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000648/gross_4.xml","form_type":"4"}},{"id":4243757,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-03T19:59:42.000Z","date":"2017-08-01","kind":"tax_withholding","acquired":false,"shares":10076,"price":1.83,"value":18439.08,"ownership":{"direct":true},"balance_after":68433,"source":{"system":"sec-edgar","filing":"0001019056-17-000648","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000648/gross_4.xml","form_type":"4"}},{"id":4243756,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-03T19:59:42.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":38093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":78509,"source":{"system":"sec-edgar","filing":"0001019056-17-000648","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000648/gross_4.xml","form_type":"4"}},{"id":4298229,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:38:20.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the \"Plan\") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":33700,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000544","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000544/gross_4.xml","form_type":"4"}},{"id":4388869,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":14506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."}],"balance_after":84235,"derivative":{"underlying":"Common Stock","underlying_shares":14506},"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388868,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":9727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 9,727 on March 9, 2017 and 9,728 on March 9, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 9,727 on March 9, 2017 and 9,728 on March 9, 2018."}],"balance_after":98741,"derivative":{"underlying":"Common Stock","underlying_shares":9727},"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388867,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":9140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019."}],"balance_after":108468,"derivative":{"underlying":"Common Stock","underlying_shares":9140},"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388866,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":3837,"price":1.78,"value":6829.86,"ownership":{"direct":true},"balance_after":40416,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388865,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":14506,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":44253,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388864,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":2573,"price":1.8,"value":4631.4,"ownership":{"direct":true},"balance_after":29747,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388863,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":9727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":32320,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388862,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":2148,"price":2.02,"value":4338.96,"ownership":{"direct":true},"balance_after":22593,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4388861,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-14T01:06:29.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":9140,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":25011,"source":{"system":"sec-edgar","filing":"0001019056-17-000290","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000290/gross_4.xml","form_type":"4"}},{"id":4421765,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-27T21:03:13.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments beginning on February 24, 2018."}],"balance_after":156339,"derivative":{"exercise_price":1.96,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000232","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000232/gross_4.xml","form_type":"4"}},{"id":4461621,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2017-02-08T23:26:49.000Z","date":"2017-02-03","kind":"exercise","acquired":false,"shares":18135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":117608,"derivative":{"underlying":"Common Stock","underlying_shares":18135},"source":{"system":"sec-edgar","filing":"0001019056-17-000109","document":"gross_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000109/gross_4.xml","form_type":"4"}},{"id":4461620,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-02-08T23:26:49.000Z","date":"2017-02-03","kind":"tax_withholding","acquired":false,"shares":5922,"price":1.92,"value":11370.24,"ownership":{"direct":true},"balance_after":15871,"source":{"system":"sec-edgar","filing":"0001019056-17-000109","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000109/gross_4.xml","form_type":"4"}},{"id":4461619,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":47677,"kind":"person","name":"Gross Jane A","position":1,"cik":"0001684258","reported_name":"Gross Jane A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-02-08T23:26:49.000Z","date":"2017-02-03","kind":"exercise","acquired":true,"shares":18135,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":21793,"source":{"system":"sec-edgar","filing":"0001019056-17-000109","document":"gross_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684258/000101905617000109/gross_4.xml","form_type":"4"}}]}